Search hospitals > Iowa > Des Moines

Mission Cancer and Blood - Laurel

Claim this profile
Des Moines, Iowa 50314
Global Leader in Cancer
Global Leader in Adenocarcinoma
Conducts research for Breast Cancer
Conducts research for Recurrence
Conducts research for Lung Cancer
172 reported clinical trials
1 medical researcher
Photo of Mission Cancer and Blood - Laurel in Des MoinesPhoto of Mission Cancer and Blood - Laurel in Des MoinesPhoto of Mission Cancer and Blood - Laurel in Des Moines

Summary

Mission Cancer and Blood - Laurel is a medical facility located in Des Moines, Iowa. This center is recognized for care of Cancer, Adenocarcinoma, Breast Cancer, Recurrence, Lung Cancer and other specialties. Mission Cancer and Blood - Laurel is involved with conducting 172 clinical trials across 330 conditions. There are 1 research doctors associated with this hospital, such as Richard L. Deming.

Area of expertise

1Cancer
Global Leader
Mission Cancer and Blood - Laurel has run 76 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Adenocarcinoma
Global Leader
Mission Cancer and Blood - Laurel has run 28 trials for Adenocarcinoma. Some of their research focus areas include:
Stage IV
Stage III
BRCA1 positive

Top PIs

Clinical Trials running at Mission Cancer and Blood - Laurel

Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Bladder Carcinoma
Squamous Cell Carcinoma
Bladder Cancer
Renal Cell Carcinoma
Colorectal Cancer
Pancreatic Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Mission Cancer and Blood - Laurel?
Mission Cancer and Blood - Laurel is a medical facility located in Des Moines, Iowa. This center is recognized for care of Cancer, Adenocarcinoma, Breast Cancer, Recurrence, Lung Cancer and other specialties. Mission Cancer and Blood - Laurel is involved with conducting 172 clinical trials across 330 conditions. There are 1 research doctors associated with this hospital, such as Richard L. Deming.